Thursday, 11 June 2020 22:14

 

The cumulative number of confirmed COVID-19 cases in South Africa is 58 568.

This is up by 3,148 cases from the 55,421 infections on Wednesday when 2,430 new cases were reported.

A further 74 COVID-19 related deaths were reported: 39 from Western Cape, 31 from the Eastern Cape, and 4 from North West.

Gender Distribution Deaths:

Male (%) Female (%) Unknown Total
653 (50,9%) 630 (49,0%) 1 (0,1%) 1284

This brings the total national deaths to 1284 with a mortality rate of 2,2%.

 

Case Data:

Province Total cases for 11 June 2020 Percentage total
Eastern Cape 7868 13,4
Free State 406 0,7
Gauteng 7953 13,6
KwaZulu-Natal 3472 5,9
Limpopo 267 0,5
Mpumalanga 228 0,4
North West 757 1,3
Northern Cape 132 0,2
Western Cape 37422 63,9
Unknown 63 0,1
Total 58568 100,0

 

Health Ministry announced that South Africa have reached a milestone- over one million tests have been completed. This was no small feat and we would like to pay tribute to all the technicians and pathologists in the NHLS and Private laboratories and all the staff who work in the most risky environment, 24 hours a day, to churn out these results.

South Africa was one of the first off the mass testing mark and we were the first country to do community screening and testing. Minister of Health also thanked the drivers from NHLS, who have been responsible for getting all 67 mobile units to all the districts and who continue to move vehicles between provinces to areas of greatest need.

1 028 399 tests have been conducted cumulatively of which 29 999 were conducted since the last report.

 

The provincial breakdown is as follows:

Province Deaths Recoveries
Eastern Cape 178 3647
Free State 9 162
Gauteng 57 2825
KwaZulu Natal 64 1572
Limpopo 3 175
Mpumalanga 1 116
North West 5 104
Northern Cape 1 42
Western Cape 966 22862
Total 1284 31505


The recoveries to date are 
33 252– this translates to a recovery rate of 56,8%.

More than 7.36 million people have now been confirmed to have the coronavirus and at least 416,000 have died, according to data from Johns Hopkins University.

A vaccine against COVID-19 developed by US biotech firm Moderna will enter the third and final stage of its clinical trial in July with 30,000 participants, the manufacturer has announced.

Compiled by Lehlohonolo Lehana.